HepaPredict is a CRO specializing in drug metabolism, toxicity, and drug development for liver disease. Using its well established long-term stable 3D spheroid model, the company offers in-house evaluations of drug metabolism, pharmacokinetic properties and safety, as well as drug target validations.
HepaPredicts ambition is to commission its scientific experience and expertise to deliver highest-quality science with the goal to support and optimize drug development efficacy and safety.
